Clinical trial
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00284076 |
|---|---|
| Title | L-Arginine in the Treatment of Peripheral Arterial Disease |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Peripheral Vascular Diseases |
| Intervention type | Drug |
| Interventions | L-arginine |
| Start date | Feb 1, 2000 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jan 31, 2006 |
| Last update posted | Mar 5, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: